AMSTERDAM – Post hoc analysis of data collected from the CANTOS trial showed that interleukin-1 blockade with canakinumab halved the rate of gout...
LIVERPOOL, ENGLAND – There is a rising rate of emergency gout admissions in England that pharmacist-led clinics could potentially help to reduce...
From the Journals
A small increase in all-cause mortality was seen with dose escalation, but only 10% of patients exceeded 300 mg allopurinol daily.
ORLANDO – FDA-mandated postmarketing safety study raises safety concerns about the gout drug.
News from the FDA/CDC
Black and American Indian/Alaska Native adults most likely to have multiple chronic health conditions.
SAN DIEGO – Clinical intuition is key to handling medical crises in rheumatology, Dr. Bharat Kumar says.
SAN DIEGO – Study provides more evidence to urge patients to hydrate.
The agency reported preliminary findings from a postmarketing safety study started after febuxostat’s approval in 2009.
SAN DIEGO – An analysis’ findings “[support] a role for additional factors in the pathogenesis of gout,” according to Nicola Dalbeth, MD.